• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估印度的卫生支出趋势和疾病负担:采用每伤残调整生命年成本法

Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach.

作者信息

Bagepally Bhavani Shankara, Kumar S Sajith, Sasidharan Akhil

机构信息

Health Technology Assessment Resource Centre, ICMR-National Institute of Epidemiology, Chennai, India.

出版信息

Clinicoecon Outcomes Res. 2024 Mar 26;16:187-196. doi: 10.2147/CEOR.S452679. eCollection 2024.

DOI:10.2147/CEOR.S452679
PMID:38560409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10981371/
Abstract

BACKGROUND

Efficient allocation of healthcare resources requires a comprehensive evaluation of healthcare spending and its impact on disease burden. This study aims to estimate the costs-per disability-adjusted life years (DALY) in India. Data from 2010 to 2019 on DALYs and health expenditure per capita (HEp) for individual states in India were utilised.

DESIGN AND METHODS

We followed the CHEERS statement 2022 to present our study's methodology and outcomes. Pearson's product-moment correlations were used to analyse associations between DALYs and HEp. A panel regression analysis was conducted using a log regression model to estimate changes in DALYs due to health expenditure changes. All costs are reported in Indian rupee (₹) along with its 95% CI, with a conversion factor of 1 US$ = ₹82.4 applied.

RESULTS

The costs-per-DALY were estimated for each state and India. DALY was negatively correlated with HEp. The estimated mean cost-per-DALY for India was ₹82,112 (₹55,810 to ₹1,08,413) [$997 ($667 to $1316)]. The mean cost per-DALY varied across states, with value of ₹27,058 (₹22,250 to ₹31,866) [$328 ($270 to $387)] for states in the first quartile based on Human Development Index (HDI) and ₹2,69,175 (₹1,05,946 to ₹4,32,404) [$3267 ($1286 to $5248)] for those in fourth HDI quartile. States such as Gujarat (0.16), Karnataka (0.17) and Maharashtra (0.22) have lower, and Arunachal Pradesh has the highest cost-per-DALY to Gross state domestic product per-capita ratio (2.41), followed by Nagaland (1.45).

CONCLUSION

Higher healthcare investment has a lower disease burden; however, reduction in DALY varies across states. Study findings provide evidence to aid the setting up of differential willingness-to-pay thresholds across Indian states for efficient and equitable healthcare resource allocation.

摘要

背景

高效分配医疗资源需要全面评估医疗支出及其对疾病负担的影响。本研究旨在估算印度每伤残调整生命年(DALY)的成本。利用了印度各邦2010年至2019年关于DALYs和人均卫生支出(HEp)的数据。

设计与方法

我们遵循2022年CHEERS声明来展示本研究的方法和结果。使用皮尔逊积矩相关性分析DALYs与HEp之间的关联。使用对数回归模型进行面板回归分析,以估算由于卫生支出变化导致的DALYs变化。所有成本均以印度卢比(₹)报告,并带有其95%置信区间,应用的换算因子为1美元 = ₹82.4。

结果

估算了印度各邦以及印度整体每DALY的成本。DALY与HEp呈负相关。印度估算的每DALY平均成本为₹82,112(₹55,810至₹1,08,413)[997美元(667美元至1316美元)]。各邦每DALY的平均成本有所不同,基于人类发展指数(HDI)处于第一四分位数的邦,其值为₹27,058(₹22,250至₹31,866)[328美元(270美元至387美元)],而处于HDI第四四分位数的邦为₹2,69,175(₹1,05,946至₹4,32,404)[3267美元(1286美元至5248美元)]。古吉拉特邦(0.16)、卡纳塔克邦(0.17)和马哈拉施特拉邦(0.22)等邦的每DALY成本较低,而阿鲁纳恰尔邦的每DALY成本与人均邦国内生产总值之比最高(2.41),其次是那加兰邦(1.45)。

结论

更高的医疗投资带来更低的疾病负担;然而,DALY的降低在各邦之间存在差异。研究结果为在印度各邦设定不同的支付意愿阈值以实现高效且公平的医疗资源分配提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/379bde58ac4f/CEOR-16-187-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/8257dcc1ff01/CEOR-16-187-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/0997048f679e/CEOR-16-187-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/379bde58ac4f/CEOR-16-187-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/8257dcc1ff01/CEOR-16-187-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/0997048f679e/CEOR-16-187-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5dc/10981371/379bde58ac4f/CEOR-16-187-g0003.jpg

相似文献

1
Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach.评估印度的卫生支出趋势和疾病负担:采用每伤残调整生命年成本法
Clinicoecon Outcomes Res. 2024 Mar 26;16:187-196. doi: 10.2147/CEOR.S452679. eCollection 2024.
2
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.低收入、中等收入和高收入国家中每避免一个伤残调整生命年的成本:来自全球疾病负担研究的证据,以估计成本效益阈值。
Cost Eff Resour Alloc. 2021 Feb 4;19(1):7. doi: 10.1186/s12962-021-00260-0.
3
Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.一国之内的差异:1990-2016 年印度各邦的疾病流行转变的流行病学差异,全球疾病负担研究。
Lancet. 2017 Dec 2;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0. Epub 2017 Nov 14.
4
Is State-Wise Healthcare Budget Allocation Consistent With the Disease Burden in India? A Quinquennial Account (2015-2019).印度各州的医疗保健预算分配与疾病负担一致吗?五年期核算(2015-2019 年)。
Front Public Health. 2022 Jun 28;10:893257. doi: 10.3389/fpubh.2022.893257. eCollection 2022.
5
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.反映价值框架内资金决策的健康机会成本:初步估计和进一步研究的需要。
Clin Ther. 2020 Jan;42(1):44-59.e2. doi: 10.1016/j.clinthera.2019.12.002. Epub 2020 Jan 16.
6
Active Tuberculosis Screening via a Mobile Health App in Myanmar: Incremental Cost-Effectiveness Evaluation.通过移动健康应用程序在缅甸进行活动性结核病筛查:增量成本效益评估。
JMIR Form Res. 2023 Nov 10;7:e51998. doi: 10.2196/51998.
7
Burden of injuries and its associated hospitalization expenditure in India.印度的伤害负担及其相关住院支出。
Int J Inj Contr Saf Promot. 2021 Jun;28(2):153-161. doi: 10.1080/17457300.2021.1879163. Epub 2021 Feb 8.
8
Disparities in the Global Burden of Age-Related Macular Degeneration: An Analysis of Trends from 1990 to 2015.全球年龄相关性黄斑变性负担的差异:1990 年至 2015 年趋势分析。
Curr Eye Res. 2019 Jun;44(6):657-663. doi: 10.1080/02713683.2019.1576907. Epub 2019 Feb 18.
9
The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019.印度各邦的神经障碍负担:1990-2019 年全球疾病负担研究。
Lancet Glob Health. 2021 Aug;9(8):e1129-e1144. doi: 10.1016/S2214-109X(21)00164-9. Epub 2021 Jul 14.
10
The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017.空气污染对印度各邦居民死亡、疾病负担和预期寿命的影响:2017 年全球疾病负担研究。
Lancet Planet Health. 2019 Jan;3(1):e26-e39. doi: 10.1016/S2542-5196(18)30261-4. Epub 2018 Dec 6.

引用本文的文献

1
Socio-economic gradients in hypertension and diabetes management amid the COVID-19 pandemic in India.印度新冠疫情期间高血压和糖尿病管理中的社会经济梯度
PLoS One. 2025 Apr 2;20(4):e0315867. doi: 10.1371/journal.pone.0315867. eCollection 2025.

本文引用的文献

1
Air pollution attributed disease burden and economic growth in India: Estimating trends and inequality between states.印度空气污染所致疾病负担与经济增长:估算各邦之间的趋势及不平等情况。
Lancet Reg Health Southeast Asia. 2022 Sep 5;7:100069. doi: 10.1016/j.lansea.2022.100069. eCollection 2022 Dec.
2
Air Pollution and Cardiovascular Disease Burden: Changing Patterns and Implications for Public Health in India.空气污染与心血管疾病负担:印度的变化模式及其对公共卫生的影响
Heart Lung Circ. 2023 Jan;32(1):90-94. doi: 10.1016/j.hlc.2022.10.012. Epub 2022 Nov 28.
3
Is State-Wise Healthcare Budget Allocation Consistent With the Disease Burden in India? A Quinquennial Account (2015-2019).
印度各州的医疗保健预算分配与疾病负担一致吗?五年期核算(2015-2019 年)。
Front Public Health. 2022 Jun 28;10:893257. doi: 10.3389/fpubh.2022.893257. eCollection 2022.
4
Mortality, morbidity and economic growth.死亡率、发病率与经济增长。
PLoS One. 2021 May 27;16(5):e0251424. doi: 10.1371/journal.pone.0251424. eCollection 2021.
5
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.低收入、中等收入和高收入国家中每避免一个伤残调整生命年的成本:来自全球疾病负担研究的证据,以估计成本效益阈值。
Cost Eff Resour Alloc. 2021 Feb 4;19(1):7. doi: 10.1186/s12962-021-00260-0.
6
Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019.印度各邦的空气污染对健康和经济的影响:2019 年全球疾病负担研究。
Lancet Planet Health. 2021 Jan;5(1):e25-e38. doi: 10.1016/S2542-5196(20)30298-9. Epub 2020 Dec 27.
7
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
8
Household out-of-pocket expenditure on health care - A cross-sectional study among urban and rural households, Puducherry.家庭医疗保健自付费用——对本地治里城乡家庭的横断面研究
J Family Med Prim Care. 2019 Jul;8(7):2278-2282. doi: 10.4103/jfmpc.jfmpc_302_19.
9
Strategies for Ensuring Quality Health Care in India: Experiences From the Field.印度确保优质医疗保健的策略:实地经验
Indian J Community Med. 2019 Jan-Mar;44(1):1-3. doi: 10.4103/ijcm.IJCM_65_19.
10
Valuing health as development: going beyond gross domestic product.重视健康就是发展:超越国内生产总值。
BMJ. 2018 Oct 23;363:k4371. doi: 10.1136/bmj.k4371.